跳至主要内容
临床试验/CTRI/2023/10/058394
CTRI/2023/10/058394尚未招募2 期

Gut microbiome and its modulation through Fecal Microbiota Transplantation (FMT) in patients with Nonalcoholic Steatohepatitis (NASH) - NI

AIIMS0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
AIIMS

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients with NAFLD liver biopsy-proven NASH
  • 2. Written informed consent
  • 3. Age between 18 and 60 years
  • 4. Non-Cirrohtic
  • 5. Any BMI

排除标准

  • Exclusion Criteria
  • 1. Patients on drugs are known to be associated with fatty liver
  • 2. Antituberculosis drugs
  • 3. Alcohol consumption ( >21 standard drinks per week in men and >14 standard drinks per
  • week in women)(1)
  • 4. Pregnant women
  • 5. Other etiology of chronic liver diseases such as hepatitis C, Wilson’s disease, autoimmune
  • liver disease, alpha-1-antitrypsin deficiency, or Hemochromatosis.
  • 6. Diabetes
  • 7. Recent antibiotic use within the last 1 month
  • 8. Probiotic intake, any gastric surgery

研究者

发起方
AIIMS

相似试验